The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

U.S. Physical Therapy Inc

NYSE: USPH
Last

(U.S.) $37.73

Today's change-0.28 -0.74%
Updated November 21 4:00 PM EST. Delayed by at least 15 minutes.
 

U.S. Physical Therapy Inc

NYSE: USPH
Last

(U.S.) $37.73

Today's change-0.28 -0.74%
Updated November 21 4:00 PM EST. Delayed by at least 15 minutes.

U.S. Physical Therapy Inc crosses below 50-day moving average

U.S. Physical Therapy Inc closed lower Friday, dropping (U.S.)$0.28 or 0.74% to (U.S.)$37.73 and crossing below its 50-day moving average. Shares have lost 2.93% over the last five days, but have gained 7.01% over the last year to date. This security has performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $38.49
  • Previous close(U.S.) $38.01
  • High(U.S.) $38.49
  • Low(U.S.) $37.51
  • Bid / Ask-- / --
  • YTD % change+7.01%
  • Volume37,506
  • Average volume (10-day)39,595
  • Average volume (1-month)49,049
  • Average volume (3-month)42,817
  • 52-week range(U.S.) $29.56 to (U.S.) $44.00
  • Beta0.93
  • Trailing P/E24.62×
  • P/E 1 year forward22.19×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $0.48
  • Dividend yield1.27%
  • Trailing EPS(U.S.) $1.53
Updated November 21 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+9.84%

Based on its net profit margin of 9.84%, U.S. Physical Therapy Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.24%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue78787069
Total other revenue--------
Total revenue78787069
Gross profit19221716
Total cost of revenue59565352
Total operating expense66646059
Selling / general / administrative7877
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)0000
Other operating expenses, total--------
Operating income1114109
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax111499
Income after tax7966
Income tax, total4433
Net income5634
Total adjustments to net income--------
Net income before extra. items5634
Minority interest-2-3-3-2
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items5634
Inc. avail. to common incl. extra. items5634
Diluted net income5634
Dilution adjustment--------
Diluted weighted average shares12121212
Diluted EPS excluding extraordinary itemsvalue per share0.430.520.270.32
Dividends per sharevalue per share0.120.120.120.10
Diluted normalized EPSvalue per share0.420.520.270.33